Literature DB >> 1755460

Use of the Home Ovarian Monitor in pregnancy avoidance.

J B Brown1, J Holmes, G Barker.   

Abstract

The application of the Home Ovarian Hormone Monitor to the avoidance of pregnancy by periodic abstinence has been explored. No woman had difficulty with the daily urine testing, and their results consistently identified the distinctive hormone pattern of the ovulatory cycle and the day of ovulation and correlated closely with the mucus symptoms. The tests gave 4 days or more warning of ovulation in 99% of cycles and allowed intercourse to be resumed 1 to 3 days after ovulation in 88%, giving a mean period of abstinence of 7 days. No pregnancy occurred from intercourse during the late safe days defined by the Monitor, but some early-day pregnancies occurred through long sperm survivals of 6 to 8 days, mostly during the return of fertility after breastfeeding. Rules for the avoidance of pregnancy, with the minimum of testing on the basis of these results, are given.

Entities:  

Keywords:  Age Factors; Australia; Contraception; Contraceptive Effectiveness; Contraceptive Usage; Demographic Factors; Developed Countries; Evaluation; Evaluation Methodology; Examinations And Diagnoses; Family Planning; Family Planning, Behavioral Methods; Laboratory Examinations And Diagnoses; Laboratory Procedures; Method Acceptability; Natural Family Planning; Obstacles; Oceania; Organization And Administration; Ovulation Detection; Pearl's Formula; Population; Population Characteristics; Population Dynamics; Research Report; Sexual Abstinence; Sympto-thermal Method; Time Factors; Use-effectiveness

Mesh:

Substances:

Year:  1991        PMID: 1755460     DOI: 10.1016/s0002-9378(11)90568-7

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  Self-Monitoring of Fertility Hormones: A New Era for Natural Family Planning?

Authors:  Leonard Blackwell; Delwyn Cooke; Simon Brown
Journal:  Linacre Q       Date:  2018-03-28

2.  Pilot observational prospective cohort study on the use of a novel home-based urinary pregnanediol 3-glucuronide (PDG) test to confirm ovulation when used as adjunct to fertility awareness methods (FAMs) stage 1.

Authors:  Rene Leiva; Marie McNamara-Kilian; Helen Niezgoda; René Ecochard; Thomas Bouchard
Journal:  BMJ Open       Date:  2019-05-27       Impact factor: 2.692

Review 3.  The Use of Estrone-3-Glucuronide and Pregnanediol-3-Glucuronide Excretion Rates to Navigate the Continuum of Ovarian Activity.

Authors:  Leonard F Blackwell; Delwyn G Cooke; Simon Brown
Journal:  Front Public Health       Date:  2018-05-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.